- Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers.
- Janysek DC, Kim J, Duijf PHG, Dray E.
- Transl Oncol. 2021 Jan 27;14(3):101012. doi: 10.1016/j.tranon.2021.101012. Epub ahead of print.
- PMID: 33516088
- PubMed abstract
- Review
- Free Full Text